Subsequently, we showed that Eritoran inhibits TLR4 signaling induced by another DAMP, high-mobility-group box 1 (HMGB1) in vitro and HMGB1 release into serum in vivo and also protects mice from PR8-induced ALI (14). The gene discussed is TLR4; the disease is acute respiratory distress syndrome.